Secura Bio, Inc.

SAN DIEGO, CA · Founded 2019 · CIK 0001771442 · Biotech · Private

Monoclonal antibodies and immunotherapeutics for autoimmune and inflammatory diseases

securabio.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$50M
1 Form D · Apr 2019
90 months since last filing
Contracts
—
No federal contracts on record
Patents
15
1 granted · 14 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$50,000,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2329CALLENTIS CONSULTING GROUP LLC——
2330Protein Dynamic Solutions, Inc.—$3.4M
2331GlycoEra——
2332Secura Bio, Inc.—$50M
2333NEMAGEN DISCOVERIES INC——
2334NEMAMETRIX, INC—$9.4M
2335TERAIMMUNE, INC.—$3.0M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 4 related persons
  • Juan EstruchExecutive Officer
  • Joseph LimberDirector · Executive Officer
  • Brett LundDirector · Executive Officer
  • Mark SpringDirector · Executive Officer

Patents

USPTO · 1 granted of 15
  • Treatment Of Cancers Using PI3 Kinase Isoform Modulatorsgranted
  • Methods Of Treating Peripheral T-cell Lymphomaapplication
  • Methods Of Making Cellular Therapiesapplication
  • Combination Therapiesapplication
  • Panobinostat Dosages For Multiple Myelomaapplication
  • Panobinostat Dosages For Multiple Myelomaapplication
  • Panobinostat Dosages For Multiple Myelomaapplication
  • Panobinostat Dosages For Multiple Myelomaapplication
  • Treatment Of Cancers Using PI3 Kinase Isoform Modulatorsapplication
  • Methods Of Treating Brain Cancer With Panobinostatapplication
  • Methods Of Making Cellular Therapiesapplication
  • Combination Therapiesapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.